Aytu Biopharma (AYTU) Net Margin (2013 - 2025)

Aytu Biopharma (AYTU) reported Net Margin of 0.41% for Q2 2025, up 890.0% year-over-year from 0.04% in Q2 2024, and up 39.98% quarter-over-quarter from 0.29% in Q1 2025.

Aytu Biopharma (AYTU) Net Margin (2013 - 2025) Analysis & Trends

Aytu Biopharma (AYTU) has 13 years of Net Margin data on file, last reported at 0.41% in Q2 2025.

  • Net Margin for Q2 2025 came in at 0.41%, up 890.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11% (up 114.0% YoY), and the FY2025 annual result was 0.93%, up 603.0% from the prior year.
  • Net Margin climbed to 0.41% in Q2 2025 per AYTU's latest filing, from 0.29% in the prior quarter.
  • Over five years, Net Margin peaked at 2.3% in Q3 2024 and troughed at 220.22% in Q1 2022.
  • A 5-year average of 36.53% and a median of 8.4% in 2023 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2021 and 2023: Net Margin plunged 9534 bps in 2021, then surged 18855 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 49.94% in 2021, then surged by 49 bps to 25.47% in 2022, then surged by 82 bps to 4.48% in 2023, then jumped by 117 bps to 0.76% in 2024, then plunged by 46 bps to 0.41% in 2025.
  • Business Quant data shows AYTU's Net Margin at 0.41% in Q2 2025, 0.29% in Q1 2025, and 0.76% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 9.19%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 26.57%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 4.16%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -168.42%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 31.38%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -15.15%
10 Aytu Biopharma 24.18 Mn -2.54 Mn 7.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.41%
Mar 31, 2025 0.29%
Dec 31, 2024 0.76%
Sep 30, 2024 2.30%
Jun 30, 2024 -8.49%
Mar 31, 2024 -4.27%
Dec 31, 2023 -4.48%
Sep 30, 2023 -3.63%
Jun 30, 2023 -8.40%
Mar 31, 2023 -31.67%
Dec 31, 2022 -25.47%
Sep 30, 2022 -2.53%
Jun 30, 2022 -58.62%
Mar 31, 2022 -220.22%
Dec 31, 2021 -49.94%
Sep 30, 2021 -127.19%
Jun 30, 2021 -79.80%
Dec 31, 2020 -62.88%
Sep 30, 2020 -31.85%
Jun 30, 2020 -54.24%